Managed Healthcare Executive February 1, 2025
Denise Myshko

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, according to new research from the University of Virginia Center for Diabetes Technology. Researchers said this could save patients with type 1 diabetes from experiencing blindness and diabetic neuropathy and other complications.

Researchers wanted to determine whether time-in-range (TIR) could be a viable marker of glycemic control. Time in range that has not been established as a surrogate marker for a clinical outcome, and researchers pointed out that the FDA has...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Technology, Wearables
Flattening the curve: How smartwatches could help stop a pandemic before it even begins
Unlocking the power of sensor data in type 2 diabetes care
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance
10 Ways Technology is Changing Healthcare - 3
Yhprum's Law applied to Healthcare Technology: Celebrate the unexpected victories because "Everything that can work, will work"

Share This Article